Search results
Ian C. Read (born 1953) is a Scottish-born American business executive and a chartered accountant, serving as executive chairman of pharmaceutical company Pfizer. [1] He was succeeded as CEO by Albert Bourla on 1 January 2019, becoming executive chairman.
Dec 5, 2010 · (BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that its Board of Directors has elected Ian C. Read, 57, currently head of the Company's global biopharmaceutical operations, as President, Chief Executive Officer and Director. Mr. Read succeeds Jeffrey B. Kindler, who has retired from the Company.
Sep 27, 2019 · Ian Read joined Pfizer in 1978. He was named CEO of Pfizer in 2010, and Chairman of the Board of Directors in 2011. “It’s been my greatest privilege to serve alongside Pfizer colleagues for the past 41 years.
May 2, 2014 · The chief executive of Pfizer had crossed the Atlantic to press the case for the US drugmaker’s proposed £63bn takeover of AstraZeneca. If successful, the deal would create the world’s ...
Dec 12, 2011 · (BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that its Board of Directors has elected current President and Chief Executive Officer, Ian Read, as Chairman of the Board and Chief Executive Officer, effective immediately. Mr. Read succeeds George Lorch as Chairman of the Board.
Sep 27, 2019 · As CEO, Pfizer's Ian Read steered the company for nine years. He's spent 41 years at the company, all told. But now, he's saying goodbye. Read, who stepped out of the CEO role in January, plans...
Oct 1, 2018 · After steering Pfizer through nine years of selloffs, spinoffs, reorgs, drug launches, patent losses, dealmaking—and one big deal that didn’t—CEO Ian Read is stepping aside.
